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Abstract
Background:  Prehepatic  portal  hypertension  in  children  can  be  asymptomatic  for  many  years.
Once diagnosed,  the  therapeutic  measures  (pharmacologic,  endoscopic,  and  surgical)  are  con-
ditioned by  the  speciﬁc  characteristics  of  each  patient.  In  Mexico,  there  are  no  recorded  data
on the  incidence  of  the  disease  and  patient  characteristics.
Aims:  To  determine  the  main  clinical,  radiologic,  and  endoscopic  characteristics  upon  diagnosis
of these  patients  at  the  Instituto  Nacional  de  Pediatría  within  the  time  frame  of  January  2001
and December  2011.
Methods:  A  cross-sectional,  retrolective,  descriptive,  and  observational  study  was  conducted  in
which all  the  medical  records  of  the  patients  with  portal  hypertension  diagnosis  were  reviewed.
Results: There  was  a  greater  prevalence  of  prehepatic  etiology  (32/52)  (61.5%)  in  the  portal
hypertension  cases  reviewed.  Males  (62.5%)  predominated  and  11  of  the  32  patients  were  under
4 years  of  age.  The  primary  reason  for  medical  consultation  was  upper  digestive  tract  bleeding
with anemia  (71.9%)  and  the  main  pathology  was  cavernomatous  degeneration  of  the  portal  vein
 Please cite this article as: Zárate Mondragón F, Romero Trujillo JO, Cervantes Bustamante R, Mora Tiscaren˜o MA, Montijo Barrios E, Cadena
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(65.6%).  Splenoportography  was  carried  out  on  17  of  the  32  patients.  A  total  of  65.5%  of  the
patients received  the  combination  therapy  of  propranolol  and  a  proton  pump  inhibitor.  Initial
endoscopy revealed  esophageal  varices  in  96.9%  of  the  patients,  12  of  whom  presented  with
gastroesophageal  varices.  Congestive  gastropathy  was  found  in  75%  of  the  patients.  The  varices
were ligated  in  8  cases,  sclerotherapy  for  esophageal  varices  was  carried  out  in  5  cases  (15.6%),
and sclerotherapy  for  gastric  varices  was  performed  in  2  patients.  Seventeen  patients  (53.1%)
underwent  portosystemic  diversion:  10  of  the  procedures  employed  a  mesocaval  shunt  and  7  a
splenorenal  shunt.  Nine  patients  (28.1%)  underwent  total  splenectomy.
Conclusions:  The  primary  cause  of  the  disease  was  cavernomatous  degeneration  of  the  portal
vein; it  was  predominant  in  males  and  the  ﬁrst  symptom  was  variceal  bleeding.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
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Características  clínicas,  radiológicas  y  endoscópicas  al  diagnóstico  de  los  pacientes
con  hipertensión  portal  prehepática  en  el  Instituto  Nacional  de  Pediatría  del  2001
al  2011
Resumen
Antecedentes:  La  hipertensión  portal  prehepática  puede  cursar  por  muchos  an˜os  asintomática
en nin˜os.  Las  medidas  terapéuticas  (farmacológicas,  endoscópicas  y  quirúrgicas)  luego  del  diag-
nóstico están  condicionadas  por  las  características  especíﬁcas  de  cada  paciente.  En  México  no
existe un  registro  que  documente  la  incidencia  y  la  caracterización  de  estos  pacientes.
Objetivo:  Determinar  las  principales  características  clínicas,  radiológicas  y  endoscópicas  al
diagnóstico  de  estos  pacientes  en  el  Instituto  Nacional  de  Pediatría  de  enero  de  2001  a  diciembre
de 2011.
Método:  Estudio  observacional,  descriptivo,  retrolectivo  y  transversal,  en  el  que  fueron  revisa-
dos todos  los  expedientes  de  pacientes  con  este  diagnóstico.
Resultados:  Mayor  prevalencia  de  etiología  prehepática  32/52  (61.5%)  de  los  casos  revisados
con diagnóstico  de  hipertensión  portal.  Predominio  de  género  masculino  (62.5%)  y  con  11/
32 pacientes  menores  de  4  an˜os.  Principal  motivo  de  consulta:  sangrado  de  tubo  digestivo
alto anemizante  (71.9%);  principal  patología:  degeneración  cavernomatosa  de  la  vena  porta
(65.6%). La  esplenoportografía  se  describió  en  17/32  pacientes.  Un  65.5%  de  los  pacientes
recibió la  combinación  terapéutica  con  propranolol  e  inhibidor  de  la  bomba  de  protones.
Endoscopia  inicial:  várices  esofágicas  en  el  96.9%.  De  estos,  12  casos  con  várices  gastroe-
sofágicas.  Gastropatía  congestiva:  75%.  Se  realizó  ligadura  de  várices  en  8  casos  (25%),
escleroterapia  de  várices  esofágicas  en  5  casos  (15.6%),  y  escleroterapia  en  várices  gástri-
cas en  2  pacientes.  En  17  pacientes  (53.1%)  fue  realizada  una  derivación  portosistémica:  en  10
ileomesocava  y  en  7  esplenorrenal.  Un  28.1%  (9  pacientes)  fueron  sometidos  a  esplenectomía
total.
Conclusiones:  La  principal  causa  fue  la  degeneración  cavernomatosa  de  la  porta,  con  una  pre-
dominancia  en  varones.  El  primer  síntoma  fue  el  sangrado  variceal.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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The  portal  vein  is  responsible  for  close  to  two  thirds  of  the
hepatic  blood  ﬂow.  It  supplies  blood  rich  in  oxygen,  nutri-
ents,  growth  factors,  and  hormones,  among  other  elements.
The  portal  vein  only  resists  low  pressures  and  portal  hyper-
tension  is  deﬁned  when  portal  pressure  exceeds  5  mmHg.
A  continuous  ﬂow  with  a  normal  range  between  15-30  cm/s
can  be  observed  through  Doppler  ultrasound.1,2
The  etiology  of  portal  hypertension  syndrome  is  varied.
Based  on  its  anatomic  classiﬁcation,  it  can  be  categorized
o
pnto  prehepatic,  intrahepatic  (presinusoidal,  sinusoidal,  and
ostsinusoidal),  and  posthepatic.  The  reported  prevalence
f  each  etiology  is  varied.  In  their  studies,  Poddar  et  al.3 and
onatone4 reported  a  predominance  in  frequency  of  prehep-
tic  portal  hypertension  over  hepatic  portal  hypertension:
8%  versus  32%  and  54%  versus  46%,  respectively.  Disease
anifestations  of  prehepatic  portal  hypertension  have  been
escribed  to  present  at  an  initial  age  of  4.6  years  and  those
f  hepatic  portal  hypertension  at  6.9  years.
The  main  causes  of  prehepatic  portal  hypertension  are:
ortal  vein  thrombosis,  cavernomatous  degeneration  of
2 F.  Zárate  Mondragón  et  al.
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Table  1  Ultrasound  ﬁndings.
Findings  documented  in  USG  Frequency  (%)
Portal  vein  ﬂow  40.6a
Portal  vein  measurement 9.3b
Presence  of  collateral  vessels 84.4
Presence  of  spontaneous  shunts  56.3
Presence  of  blood  ﬂow  obstruction  28.1
Presence  of  extrinsic  compression  6.3
a Of the 13 patients in whom portal vein ﬂow was  described,
only 3 had a value--in accordance with the literature-- that was
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he  portal  vein,  and  splenic  vein  thrombosis.  Other  causes,
o  a  lesser  degree,  are  congenital  malformations  of  the
ortal  vein  and  Klatskin  tumor.  The  ﬁrst  2  of  the  abovemen-
ioned  pathologies  are  the  most  studied.  The  primary  initial
linical  manifestation  of  prehepatic  portal  hypertension  is
pper  gastrointestinal  bleeding;  close  to  90-95%  of  these
atients  have  esophageal  varices  and  35-40%  have  gastric
arices.5
Doppler  USG,  splenoportography,  magnetic  resonance
ngiography,  and  angiotomography  are  among  the  diagnostic
tudies  utilized  for  this  disease.
There  are  2  important  treatment  aspects:  a)  medical
reatment,  with  medications  like  propranolol,  ranitidine,
r  a  proton  pump  inhibitor;  2)  endoscopic  treatment  of
arices;  there  are  few  pediatric  studies  comparing  liga-
ion  versus  sclerotherapy,  and  3)  surgical  treatment, with
ortosystemic  shunts  (total  or  selective),  splenectomy,  or
artial  embolization.
The  primary  aim  of  this  study  was  to  determine  the
ain  clinical,  radiologic,  and  endoscopic  characteristics  of
atients  upon  diagnosis  with  prehepatic  portal  hypertension
t  the  Instituto  Nacional  de  Pediatría  within  the  time  frame
f  January  2001  and  December  2011.
ethods
n  observational,  descriptive,  retrolective,  and  cross-
ectional  study  was  conducted.  The  protocol  was  accepted
y  the  Research  and  Ethics  Committee  of  the  Instituto
acional  de  Pediatría.  A  search  of  the  Clinical  Archive
atabase  of  all  the  medical  records  with  conﬁrmed  diag-
osis  was  carried  out.  Fifty-two  clinical  case  records  were
btained  of  patients  seen  at  the  institution  from  January
,  2001  to  December  31,  2011.  Of  these,  32  had  prehep-
tic  etiology  and  were  included  in  the  review.  Demographic,
linical,  imaging,  and  treatment  (medical  and  surgical)
ariables  were  analyzed.  Employing  the  SPSS  software  ver-
ion  19.0,  the  quantitative  variables  were  analyzed  through
he  descriptive  statistics  of  measures  of  central  tendency,
ispersion,  and  normality  tests  and  the  categorical  variables
hrough  frequencies  and  percentages.
esults
he  diagnoses  contained  in  the  52  medical  records  initially
eviewed  were  distributed  as  follows:
Prehepatic  portal  hypertension:  32  patients  (61.5%).
Presinusoidal  intrahepatic  portal  hypertension:  6  pat-
ents  (11.5%),  all  diagnosed  with  hepatoportal  sclerosis.
Sinusoidal  intrahepatic  portal  hypertension:  12  patients
23%).  The  reported  diagnoses  were:  biliary  atresia  (5),
utoimmune  hepatitis  (3),  neonatal  hepatitis  (1),  lysoso-
al  disease  (1),  liver  abscess  (1),  and  alpha  1  antitrypsin
eﬁciency  (1).
Posthepatic  portal  hypertension:  2  patients  (4%):  one
atient  with  scimitar  syndrome  and  the  other  with  altered
ow  of  the  inferior  vena  cava.Thirty-two  patients  diagnosed  with  prehepatic  portal
ypertension  were  included  in  this  study:  12  patients  (37.5%)
ere  female  and  20  (62.5%)  were  male.  The  median  age
t  the  time  of  diagnosis  was  107  months  (minimum  of
t
(
t
vsuggestive of portal hypertension.
b Of these 3 patients, only one had the value--suggested in the
literature--that indicated portal hypertension.
 months  and  maximum  of  181  months),  of  which  4  chil-
ren  (12.5%)  were  0 to  12  months  old,  15  (46.88%)  between
 and  4  years  old,  7  (21.88%)  between  5  and  9  years  old,  5
15.62%)  between  10  and  13  years  old,  and  one  case  (3.12%)
etween  14  and  18  years  old.  The  median  weight  was  17  kg
a  minimum  of  4.06  and  maximum  of  62  kg).  The  median
eight  was  102  cm  (a  minimum  of  58  cm  and  maximum  of
62  cm).
linical  symptoms
he  main  reason  medical  consultation  was  sought  was  upper
astrointestinal  bleeding  with  anemia  (deﬁned  as  a  reduc-
ion  in  hemoglobin  of  more  than  2  g  from  the  baseline  value
r  hemodynamic  repercussion)  in  23  cases  (71.9%);  hyper-
plenism  in  5  cases  (15.6%)  (characterized  by  leukopenia  and
hrombocytopenia),  upper  gastrointestinal  bleeding  with-
ut  anemia  in  2 cases  (6.3%),  and  isolated  splenomegaly  in
 cases  (6.3%).
iagnosis
he  principal  diagnosis  was  cavernomatous  degeneration  of
he  portal  vein  in  21  cases  (65.6%),  followed  by  portal  vein
hrombosis  in  6  cases  (18.8%),  and  splenic  vein  thrombosis
n  5  cases  (15.6%).  The  previous  placement  of  an  umbilical
atheter  was  reported  in  only  10  cases,  and  protein  C  and  S
eﬁciency  was  found  in  only  2  cases.
maging  studies
oppler  USG  was  carried  out  on  all  the  patients.  Portal
ein  ﬂow  measured  in  cm/s  with  a  minimum  value  of  11,
 maximum  value  of  50,  and  a  median  value  of  21.3  was
escribed  in  13  patients  (40.6%).  In  order  of  frequency,
he  USG  reported  the  presence  of  collateral  circulation  in
7  patients  (84.4%),  blood  ﬂow  obstruction  in  18  patients
56.3%),  spontaneous  shunts  in  9  patients  (28.1%),  and
xtrinsic  compression  in  2  patients  (6.3%)  (table  1).
Splenoportography  was  carried  out  on  17  of  the
2  patients;  it  revealed  a  «balled  up» image  characteris-
ic  of  portal  vein  cavernomatous  degeneration  in  7  cases
21.9%);  an  image  of  «blocked  ﬂow» was  observed  in  15.6%  of
he  cases,  corresponding  to  portal  vein  thrombosis;  splenic
ein  obstruction  was  identiﬁed  in  4  cases  (12.4%);  and  the
gnos
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presence  of  collateral  vessels  was  shown  in  only  one  case
(3.1%).
Angiotomography  was  performed  on  only  5  patients
(15.62%)  and  revealed  splenomegaly  in  all  of  them,  col-
lateral  vessels  in  4,  blood  ﬂow  obstruction  in  2,  and
spontaneous  shunts  in  one  case.
Magnetic  resonance  angiography  was  carried  out  on
14  patients  (43.75%)  and  identiﬁed  splenomegaly  and  col-
lateral  vessels  in  13  patients,  blood  ﬂow  obstruction  in  7
patients,  and  spontaneous  shunts  in  6  patients.
Medical  and  surgical  treatment
In  relation  to  medical  treatment,  65.5%  of  the  cases
(21  patients)  received  the  combination  of  propranolol
(dose  of  1-2  mg/kg/day)  and  a  proton  pump  inhibitor
(1  mg/kg/day);  34.5%  (11  patients)  received  propranolol  and
ranitidine  at  the  time  of  diagnosis.
Initial  panendoscopy  reported:  grade  ii  esophageal
varices  in  12  patients  (37.5%),  grade  iii  in  19  patients
(59.4%),  and  no  esophageal  varices  in  one  case  (3.1%);
gastroesophageal  varices  in  12  cases  (37.5%),  9  of  them
with  the  GOV  1  classiﬁcation  and  3  with  GOV  2  classiﬁcation.
Seventy-ﬁve  percent  of  the  patients  (24  cases)  presented
with  congestive  gastropathy.
Variceal  ligation  was  performed  in  8  cases  (25%)  and
sclerotherapy  of  esophageal  varices  in  5  cases  (15.6%);  the
sclerotherapy  was  paravariceal  in  one  of  the  cases  and
not  speciﬁed  in  the  other  4  cases.  Sclerotherapy  of  gastric
varices  was  carried  out  on  2  patients  (6.2%);  it  was  par-
avariceal  in  one  of  the  cases  and  not  speciﬁed  in  the  other
case.
Portosystemic  shunting  was  performed  on  17  patients
(53.1%);  10  of  those  patients  had  mesocaval  shunt  place-
ment  and  7  had  a  splenorenal  shunt.  Nine  patients  (28.1%)
underwent  total  splenectomy.  Performing  shunt  placement
in  children  depends  more  on  the  age  of  the  patient  than
the  diagnosis,  on  the  caliber  and  anatomic  situation  of  the
vessels  (analyzed  through  an  imaging  study  that  aids  in  eval-
uating  the  collateral  veins  and  in  determining  which  vein
is  the  most  appropriate  for  performing  the  diversion)  and
ﬁnally,  the  experience  of  the  surgeon.
Discussion
In  our  study,  we  found  a  61.5%  prevalence  of  prehep-
atic  etiology  in  the  portal  hypertension  cases,  which  is  in
accordance  with  the  values  described  in  the  literature.3,4
Nevertheless,  we  believe  there  is  an  under-registering  of
cases  of  biliary  atresia  and  other  etiologies  that  progress
to  cirrhosis,  and  consequently  to  cases  of  intrahepatic
portal  hypertension;  therefore  we  cannot  afﬁrm  that  pre-
hepatic  portal  hypertension  is  the  most  frequent  cause  of  all
the  portal  hypertensions.
We  found  a  higher  frequency  in  males  (62.5%)  in  our  case
series,  which  was  interesting,  given  that  this  predisposition
is  not  observed  in  other  published  reports.  At  the  time  of
diagnosis,  the  values  of  the  age,  weight,  and  height  varia-
bles  were  very  different,  which  also  is  in  contrast  with  that
reported  in  the  literature;  in  the  majority  of  the  studies,
the  patients  are  older  than  4  years  of  age,  whereas  in  our
s
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sis  of  patients  247
eries,  19  patients  (59%)  were  diagnosed  under  the  age  of
 years.3--9
Upper  gastrointestinal  bleeding  secondary  to  esophageal
arices  was  the  primary  clinical  manifestation  at  the  time  of
iagnosis,  correlating  with  that  reported  in  the  literature.3--9
leeding  together  with  anemia  was  found  in  the  majority  of
he  cases  (71.9%)  and  bleeding  without  anemia  in  6.3%.  This
lso  correlates  with  studies  in  the  literature  stating  that
t  the  time  of  diagnosis,  the  majority  of  patients  require
ransfusions  of  blood  derivatives  in  order  to  achieve  hemo-
ynamic  stability,  resulting  in  a  2  to  5%  mortality  rate.5 It
s  striking  that  in  the  patients  that  were  initially  evaluated
ue  to  hypersplenism  or  isolated  splenomegaly,  the  etiol-
gy  was  regarded  as  hematologic  and  oncologic.  However,
t  should  be  kept  in  mind  that  that  the  cause  could  be  pre-
epatic  portal  hypertension,  as  occurred  with  our  patients.
he  leading  case  series7,8,10 describe  cavernomatous  degen-
ration  and  portal  vein  thrombosis  as  the  main  etiologic
actors  of  this  pathology,  which  is  in  accordance  with  the
ndings  of  our  case  series,  in  which  we  found  that  84.4%
f  the  cases,  as  a  whole,  corresponded  to  these  patholo-
ies.
Doppler  ultrasound  is  the  ﬁrst  imaging  study  that  should
e  carried  out  in  the  initial  approach  to  these  patients,11
ecause  it  enables  the  measuring  of  ﬂow  velocity  (mea-
ured  in  cm/s);  according  to  the  literature,  the  diagnosis  of
ortal  hypertension  is  made  when  there  are  values  above
5-30.  In  our  study,  ﬂow  velocity  was  measured  in  just
3  of  the  patients,  only  3  of  which  met  the  portal  hyper-
ension  criterion  of  that  value  described  in  the  literature.
his  is  also  an  interesting  ﬁnding,  given  that  high  sensitiv-
ty  and  speciﬁcity  have  been  reported  for  this  diagnostic
tudy.  However,  it  is  possible  that  these  values  were  actu-
lly  higher,  if  we  take  into  account  the  fact  that  the  majority
f  patients  presented  with  grade  ii  and  iii  esophageal  varices
t  the  time  of  diagnosis.  Published  reports  indicate  that
SG  reliably  shows  the  presence  of  collateral  veins  and
nables  a  nonspeciﬁc  determination  of  the  ﬂow  obstruc-
ion  site.  This  concurs  with  our  ﬁndings  of  collateral  vessels
84.4%  of  the  imaging  studies)  and  blood  ﬂow  obstruction
56.3%).5,11
Splenoportography  was  performed  on  approximately  half
f  the  documented  patients  (53%),  and  was  the  main  diag-
ostic  study  in  this  group  of  patients  from  2001  to  2006,
he  ﬁrst  5  years  of  the  time  frame  of  our  analysis.  As
escribed  in  the  literature,  this  technique  stopped  being
sed  and  has  been  replaced  by  angiotomography  and  mag-
etic  resonance  angiography  because  they  provide  the  same
nformation  and  are  noninvasive  studies,11--13 explaining  why
plenoportography  was  not  indicated  for  the  patients  at
he  Instituto  Nacional  de  Pediatría  during  the  period  of
ime  corresponding  to  the  last  5  years  of  our  study  time
rame.
There  are  no  studies  in  the  literature  that  compare
ngiotomography  and  magnetic  resonance  angiography  and
ndicate  that  one  diagnostic  method  is  better  than  the  other
or  this  pathology.  Both  methods  deﬁne  images  character-
stic  of  collateral  vessels,  ﬂow  obstruction,  spontaneous
hunts,  and  splenomegaly;  magnetic  resonance  angiography
as  a slightly  higher  sensitivity  and  speciﬁcity,11 depend-
ng  on  the  researcher  and  the  institution  carrying  out  the
tudy.  Magnetic  resonance  angiography  is  performed  more
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148  
requently  (43.75%)  than  angiotomography;  collateral  ves-
els  and  splenomegaly  were  the  most  frequent  ﬁndings  in
ach  of  these  methods.
Propranolol  is  mentioned  in  the  literature  as  a  reg-
lar  part  of  medical  treatment,14--17 and  was  indicated
or  100%  of  the  study  patients.  In  recent  studies,  proton
ump  inhibitors  are  used  to  inhibit  hydrochloric  acid  (tak-
ng  into  account  their  mechanism  of  action).  Nevertheless,
n  our  institution  they  were  only  prescribed  to  65.5%  of
he  patients.  Ranitidine  was  indicated  for  the  rest  of  the
atients;  this  drug  has  not  been  the  treatment  of  choice  for
he  last  few  years,  not  only  because  of  its  limited  action
ompared  to  that  of  the  proton  pump  inhibitors,  but  also
ue  to  its  high  risk  for  tachyphylaxis.
Upper  gastrointestinal  bleeding  secondary  to  esophageal
arices  is  regularly  described  in  the  literature,  reporting  a
revalence  of  up  to  90-95%  in  the  patients  with  prehepatic
ortal  hypertension.5 In  our  study,  the  presence  of  grade  ii
nd  iii  esophageal  varices  made  up  97%  of  the  cases,  explain-
ng  the  high  risk  for  bleeding  and  the  reason  for  the  ﬁrst
edical  consultation.  It  has  been  stated  that  gastric  varices
ay  be  present  in  up  to  40%  of  cases;  gastroesophageal
arices  were  found  in  37.5%  of  cases  at  the  Instituto  Nacional
e  Pediatría,  but  not  a  single  case  of  isolated  gastric  varices.
astropathy  has  been  directly  correlated  with  the  degree
f  liver  involvement;5 almost  all  of  these  patients  present
ith  grade  ii  and  iii  esophageal  varices,  which  is  directly  cor-
elated  with  the  75%  prevalence  of  congestive  gastropathy
n  this  study.
The  use  of  ligatures  or  sclerotherapy  in  the  treatment  of
sophageal  varices  is  controversial  and  there  are  few  pedi-
tric  studies  on  this  subject.  Some  reports  have  described
oth  procedures  as  having  long-term  management  efﬁcacy,
ut  ligation  has  been  shown  to  reduce  the  number  of  ses-
ions  required  and  has  a  lower  percentage  of  bleeding
ecurrence  and  secondary  complications.16--18 In  the  present
tudy,  ligation  was  documented  in  8  patients  and  scle-
otherapy  in  5.  In  the  follow-up  period,  4  more  patients
eceived  sclerotherapy  treatment.  This  is  explained  by  the
act  that  in  the  ﬁrst  5  years  covered  in  our  review  (2001
o  2006)  the  patients  were  quickly  treated  with  portosys-
emic  shunt  placement,  considerably  reducing  the  grade
f  esophageal  varices,  and  thus  resulting  in  a smaller
umber  of  procedures.  It  is  interesting  to  point  out  that
lthough  ligatures  have  been  available  at  the  Institute  for
nly  5  years,  this  procedure  has  been  carried  out  more
requently  than  sclerotherapy,  according  to  the  data  we
ollected.
We  found  no  study  indicating  a  predominance  of  a  speciﬁc
ortosystemic  shunt  in  this  disease.  They  are  recommended
o  always  be  evaluated  individually,  after  documenting
he  collateral  vessels,  their  distribution,  and  ﬂow  veloc-
ties  and  they  should  not  be  considered  an  emergency
rocedure.15,19 Portosystemic  shunt  was  carried  out  on  17
ases  (53%)  in  the  present  analysis.  It  is  striking  that  all
f  the  patients  receiving  a  mesocaval  shunt  underwent
his  procedure  during  the  ﬁrst  month  of  evaluation.  Cer-
ain  advantages  to  distal  splenorenal  shunt  have  been
eported  in  relation  to  the  rest  of  the  total  shunts,6,19
ut  mesocaval  shunt  (10  cases)  predominated  over  distal
plenorenal  shunt  (7  cases)  in  this  study.  The  surgical  option
f  splenectomy  was  contemplated  in  9  patients,  though  it
1F.  Zárate  Mondragón  et  al.
s  not  a  ﬁrst  choice  procedure  in  the  follow-up  of  these
atients.6
onclusions
rehepatic  portal  hypertension  is  an  entity  with  a  high  mor-
idity  rate,  and  therefore  it  is  important  that  the  physician
e  familiarized  with  this  disease  so  that  the  patient  can  be
eferred  to  a  tertiary  care  center  for  opportune  diagnosis
nd  treatment.
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